PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

Detalles Bibliográficos
Autores principales: Vitolo, Umberto, Phillips, Elizabeth H., Alonso, Aránzazu Alonso, Merli, Michele, Risal, Ashish, Namuduri, Manjusha, Shen, Biyi, Flink, Dina, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Cordoba, Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429454/
http://dx.doi.org/10.1097/01.HS9.0000975796.49668.c2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429454/
http://dx.doi.org/10.1097/01.HS9.0000975796.49668.c2

Ejemplares similares